EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Fluidigm Raises $5M

South San Francisco, CA-based Fluidigm, which makes instruments for measuring gene expression in single cells such as tumor cells, has raised $5 million in an offering of debt, options, and securities, according to a January 20 regulatory filing. The firm may have needed the funds to tide it over on its way to a planned initial public offering; the company restarted the paperwork for its IPO just last month, after abandoning plans to go public in 2008.